Position in NVS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,909,741
+$1,512,655 QoQ
Shares Held
38,689
+21.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Advisory Services Network, LLC holds $159,480,021 across 17 Drug Manufacturers - General names. NVS ranks #8 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
50,669 | $46,603,818 | |
| 2 | ABBV |
AbbVie Inc.
|
118,301 | $25,729,278 | |
| 3 | JNJ |
Johnson & Johnson
|
86,066 | $21,037,966 | |
| 4 | MRK |
Merck & Co., Inc.
|
143,304 | $17,238,032 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
74,137 | $10,332,465 | |
| 6 | AMGN |
Amgen Inc
|
29,101 | $10,239,178 | |
| 7 | PFE |
Pfizer Inc
|
258,469 | $7,257,803 | |
| 8 | NVS |
Novartis AG
This page
|
38,689 | $5,909,741 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,909,741 | 38,689 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,397,086 | 31,893 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,084,697 | 31,852 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $3,884,660 | 32,102 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $3,495,454 | 31,355 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,394,073 | 34,879 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,031,564 | 35,051 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,731,528 | 35,051 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,590,712 | 37,121 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $3,496,590 | 34,630 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $3,691,404 | 36,240 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,087,459 | 40,506 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $3,315,128 | 36,034 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $3,093,369 | 34,098 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,737,043 | 36,009 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,161,748 | 49,234 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $3,959,805 | 45,126 | Shares | Sole | 2022-05-23 | |
| 2021-12-31 | $3,223,706 | 36,855 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,962,723 | 36,228 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $2,780,537 | 30,475 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,640,817 | 30,894 | Shares | Sole | 2021-05-24 | |
| 2020-12-31 | $2,370,191 | 25,100 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $2,152,780 | 24,756 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,173,716 | 24,888 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $1,767,396 | 21,436 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||